Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes-Reference-Cited by-同舟云学术

Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes

Published:2022-09-22 Issue:19 Volume:65 Page:13264-13287
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hanke Thomas¹²^ORCID,Mathea Sebastian¹²,Woortman Julia³,Salah Eidarus⁴,Berger Benedict-Tilman¹²^ORCID,Tumber Anthony⁴,Kashima Risa⁵,Hata Akiko⁵,Kuster Bernhard³⁶^ORCID,Müller Susanne¹²^ORCID,Knapp Stefan¹²⁶^ORCID

Affiliation:

1. Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany

2. Structural Genomics Consortium (SGC), Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany

3. Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), D-85354 Freising, Germany

4. Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom

5. Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94143, United States

6. German Translational Cancer Network (DKTK), Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

Funder

Merck KGaA

Deutschen Konsortium f?r Translationale Krebsforschung

Takeda Pharmaceutical Company

Deutsche Forschungsgemeinschaft

Pfizer

Innovative Medicines Initiative

Janssen

Frankfurt Cancer Institute

Publisher

American Chemical Society (ACS)

Subject